第一单位：
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
作者：
Ramesh,Utharala [1]
;
Anna,Grab [2]
;
Vida,Vafaizadeh [3]
;
Nicolas,Peschke [1]
;
Martine,Ballinger [4]
;
Denes,Turei [5]
;
Nadine,Tuechler [1]
;
Wenwei,Ma [1]
;
Olga,Ivanova [6]
;
Alejandro Gil,Ortiz [1]
;
Julio,Saez-Rodriguez [7]
;
Christoph A,Merten [8]
作者单位：
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
[1]
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.;Clinical Cooperation Unit Molecular Hematology/Oncology, DKFZ Heidelberg and Translational Myeloma Research Group, Department of Internal Medicine V, University Hospital, Heidelberg, Germany.
[2]
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.;Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
[3]
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.;Collaboration for joint PhD degree between EMBL and Heidelberg University, Faculty of Biosciences, Heidelberg, Germany.
[4]
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.;Faculty of Medicine and Heidelberg University Hospital, Institute of Computational Biomedicine, Heidelberg University, Heidelberg, Germany.
[5]
Faculty of Medicine and Heidelberg University Hospital, Institute of Computational Biomedicine, Heidelberg University, Heidelberg, Germany.
[6]
Faculty of Medicine and Heidelberg University Hospital, Institute of Computational Biomedicine, Heidelberg University, Heidelberg, Germany.;Faculty of Medicine, Joint Research Centre for Computational Biomedicine (JRC-COMBINE), RWTH Aachen University, Aachen, Germany.
[7]
Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. christoph.merten@epfl.ch.
[8]
DOI
10.1038/s41596-022-00740-4
PMID
36261631
发布时间
2024-08-29
换一批
换一批
